API Faropenem CAS 106560-14-9

Faropenem More Info

Pharmacological Properties

Classification: Faropenem belongs to the class of carbapenem antibiotics. It has a broad antibacterial spectrum and strong antibacterial activity, which enables it to effectively combat a variety of bacterial infections.

Mechanism of Action: It works by inhibiting the synthesis of the bacterial cell wall. Specifically, it binds to penicillin-binding proteins (PBPs) in the bacterial cell wall, thereby preventing the cross-linking of peptidoglycan chains, which is essential for the stability and integrity of the cell wall. As a result, the bacteria are unable to maintain their normal shape and structure, leading to cell lysis and death.

Clinical Applications

Respiratory Tract Infections: Faropenem is commonly used in the treatment of various respiratory tract infections, such as pneumonia, bronchitis, and sinusitis. It can effectively kill the bacteria causing these infections, relieve symptoms such as cough, sputum production, and shortness of breath, and help patients recover quickly.

Urinary Tract Infections: It is also widely used in treating urinary tract infections. Whether it is cystitis or pyelonephritis, faropenem can play a good antibacterial role, eliminating the bacteria in the urinary tract and reducing symptoms like frequent urination, urgent urination, and painful urination.

Skin and Soft Tissue Infections: For skin and soft tissue infections, including cellulitis, abscesses, and wound infections, faropenem can be an effective treatment option. It can penetrate into the infected tissues and kill the pathogenic bacteria, promoting wound healing and reducing inflammation.

Advantages

Broad Antibacterial Spectrum: It has activity against a wide range of Gram-positive and Gram-negative bacteria, including many drug-resistant strains, which makes it a valuable therapeutic option in cases where the pathogen is difficult to identify or is resistant to other antibiotics.

Good Oral Bioavailability: Faropenem can be administered orally, and it has good absorption in the gastrointestinal tract, which means that patients can take it conveniently at home without the need for intravenous injection in some cases. This improves patient compliance and simplifies the treatment process.

Low Toxicity: Generally, faropenem has a relatively low toxicity profile. It has fewer adverse effects on the body compared to some other antibiotics, and the incidence of serious adverse reactions is relatively low, which increases the safety of its use in patients.